At NCI, I build and facilitate biomedical technology development initiatives and partnerships across agencies and sectors to accelerate cancer research and shift the paradigm for cancer diagnosis, treatment, and prevention as part of the NCI director’s Office of Technology and Industrial Relations (technology.cancer.gov), where I joined in 2003 as NCI was starting to plan comprehensive nanotechnology and proteomics initiatives. I was mainly instrumental in planning, coordinating, and implementing the NCI Alliance for Nanotechnology in Cancer (nano.cancer.gov), a ground-breaking five-year, $144 million initiative, devising and establishing program structure and providing technical analyses.

I am currently on detail to the White House Office of Science and Technology Policy (www.ostp.gov) as a National Science and Technology Council (NSTC) representative focused on nanobiotechnology and related environmental, health, safety, and ethical issues.